Beijing Da Xue Xue Bao Yi Xue Ban
August 2011
Objective: To explore the role of microRNA-184(MIR-184) in the development of renal cell carcinoma(RCC).
Methods: The expressions of MIR-184 in 51 patients with RCC Investigated, normal adjacent tissues (ADTs) matched by fluorescence quantitative PCR technology (RT-qPCR) and the correlations analyzed between MIR-184 expression and the age, gender and clinical stage of RCC patients.
Results: The average expression of MIR-184 in RCC was -14.